APA (7th ed.) Citation

W, W., X, X., C, R., H, Z., J, S., M, W., . . . C, H. (2026). Inhibition of TGM2 enhances cisplatin sensitivity in MSH2-deficient bladder cancer. Cell death discovery, 12(1), . https://doi.org/10.1038/s41420-026-03182-z

Chicago Style (17th ed.) Citation

W, Wei, et al. "Inhibition of TGM2 Enhances Cisplatin Sensitivity in MSH2-deficient Bladder Cancer." Cell Death Discovery 12, no. 1 (2026). https://doi.org/10.1038/s41420-026-03182-z.

MLA (9th ed.) Citation

W, Wei, et al. "Inhibition of TGM2 Enhances Cisplatin Sensitivity in MSH2-deficient Bladder Cancer." Cell Death Discovery, vol. 12, no. 1, 2026, https://doi.org/10.1038/s41420-026-03182-z.